Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
Business
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
Related
Business
Morning Minute: Robinhood Adds Perps, Weekend Stocks, and AI Traders
Robinhood is leaning deeper into crypto as they look to unlock their “everything app” vision.
Business
Is the Meme Coin Era Ending? Tokenized Stocks Just Took 11% of DEX Trading
Tokenized stocks averaged 11% of decentralized exchange (DEX) trading in September, according to Binance Research. Meme coins averaged 17% over the same month, leaving a gap of six percentage points. The report suggests equities are absorb…
Business
‘I’m afraid of human stupidity.’ Why this top economist prefers U.S. tech and gold over bonds.
A prominent economist doesn’t fear artificial intelligence, but fully embraces it in portfolios. He feels far differently about government debt.
Business
Anthropic’s IPO doubles the price of its own books
Anthropic’s Series H round priced the company at $965B, yet its IPO now wants double that valuation on the same 2025 financials. The post Anthropic’s IPO doubles the price of its own books appeared first on Protos.